CLDX — Celldex Therapeutics Inc · rev $37.0K

Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.

Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.

Use this CLDX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CLDX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CLDX SEC filings page. Lician reads the product cache first so this HTML stays unique to Celldex Therapeutics Inc even when a live quote feed is slow.

Celldex Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full CLDX income, balance, and cash tables.

  • Revenue$1.5M
  • Net Income-$258.8M
  • Total Assets$583.0M
  • Total Debt$0
  • Free Cash Flow-$213.7M

CLDX recent filings